Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 6
2013 3
2014 8
2015 5
2016 11
2017 6
2018 8
2019 12
2020 11
2021 9
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.
Mills MN, Uno A, Li P, Liveringhouse C, Kim Y, Oliver DE, Perez BA, Creelan BC, Yu M, Forsyth PA, Pina Y, Ahmed KA. Mills MN, et al. Among authors: ahmed ka. Clin Lung Cancer. 2024 Apr 10:S1525-7304(24)00048-2. doi: 10.1016/j.cllc.2024.04.005. Online ahead of print. Clin Lung Cancer. 2024. PMID: 38719648
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.
Dohm AE, Nakashima JY, Kalagotla H, Jiang SX, Tang JD, Bhandari M, Kim Y, Graham JA, Khushalani NI, Forsyth PA, Etame AB, Liu JK, Tran ND, Vogelbaum MA, Wuthrick EJ, Yu HM, Oliver DE, Ahmed KA. Dohm AE, et al. Among authors: ahmed ka. Eur J Cancer. 2023 Oct;192:113287. doi: 10.1016/j.ejca.2023.113287. Epub 2023 Aug 7. Eur J Cancer. 2023. PMID: 37657227
Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma.
Liveringhouse CL, Palm RF, Bryant JM, Yang GQ, Mills MN, Figura ND, Ahmed KA, Mullinax J, Gonzalez R, Johnstone PA, Naghavi AO. Liveringhouse CL, et al. Among authors: ahmed ka. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):123-138. doi: 10.1016/j.ijrobp.2023.03.037. Epub 2023 Mar 18. Int J Radiat Oncol Biol Phys. 2023. PMID: 36935026 Clinical Trial.
Phase 2 Study of Preoperative SABR for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiation Therapy.
Liveringhouse CL, Mills MN, Ahmed KA, Washington IR, Lee MC, Khakpour N, Laronga C, Czerniecki B, Soliman H, Weinfurtner RJ, Rosa M, Kim Y, Stringfield O, Abdalah M, Diaz R, Montejo M. Liveringhouse CL, et al. Among authors: ahmed ka. Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):611-616. doi: 10.1016/j.ijrobp.2022.12.036. Epub 2023 Feb 15. Int J Radiat Oncol Biol Phys. 2023. PMID: 36796498 Clinical Trial. No abstract available.
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone.
Dohm AE, Tang JD, Mills MN, Liveringhouse CL, Sandoval ML, Perez BA, Robinson TJ, Creelan BC, Gray JE, Etame AB, Vogelbaum MA, Forsyth P, Yu HM, Oliver DE, Ahmed KA. Dohm AE, et al. Among authors: ahmed ka. J Neurosurg. 2022 Nov 11;138(6):1600-1607. doi: 10.3171/2022.9.JNS221896. Print 2023 Jun 1. J Neurosurg. 2022. PMID: 36681988
85 results